Whatever your goals, even if you’re training to run long, it pays to go short—and fast.
An independent international safety monitoring board has given the ENIGMA-TRS 1 trial the go-ahead to continue as planned in schizophrenia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results